Tirzepatide vs semaglutide after treatment failure

A 5% benchmark can help put a limited response to semaglutide in context: in obesity pharmacotherapy, nonresponse is often defined as not losing at…

A 5% benchmark can help put a limited response to semaglutide in context: in obesity pharmacotherapy, nonresponse is often defined as not losing at…